We are live on
!
Find out more
NKGN
NKGen Biotech, Inc. Common Stock
NKGN
NKGN
Delisted
NKGN was delisted on the 4th of March, 2025.
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Millennium Management
New York
| $910K | +$916K | +93,900 | New |
|
|
GCIA
27
Gabelli & Co Investment Advisers
Rye,
New York
| $835K | +$840K | +86,200 | New |
|
|
EAM
28
Exos Asset Management
New York
| $678K | +$683K | +70,000 | New |
|
|
TI
29
Telemetry Investments
New York
| $524K | +$527K | +54,061 | New |
|
30
Walleye Capital
New York
| $508K | +$511K | +52,397 | New |
|
31
Marshall Wace
London,
United Kingdom
| $490K | +$493K | +50,537 | New |
|
|
EIP
32
Easterly Investment Partners
Beverly,
Massachusetts
| $485K | +$488K | +50,000 | New |
|
33
Walleye Trading
New York
| $349K | +$351K | +36,000 | New |
|
34
HighTower Advisors
Chicago,
Illinois
| $327K | +$331K | +33,900 | New |
|
|
FBCM
35
Fort Baker Capital Management
Larkspur,
California
| $240K | +$241K | +24,714 | New |
|
|
SSA
36
Schonfeld Strategic Advisors
New York
| $140K | +$141K | +14,451 | New |
|
37
JP Morgan Chase
New York
| $80K | +$80.3K | +8,237 | New |
|